Mouse model of alcohol-induced liver cancer
View Patent ↗Described are alcohol-induced liver cancer model mice, methods of generating the alcohol-induced liver cancer model mice, and methods of using the alcohol-induced liver cancer model mice. Methods of treating alcoholic liver disease, including hepatocellular carcinoma, are also described.
1. A mouse model of alcohol-induced liver cancer wherein the mice have been treated with streptozotocin in an amount to induce a diabetic phenotype and fed an alcohol-containing diet.
2. The mouse model of claim 1 , wherein the mice are administered streptozotocin on day 2, 3, 4, or 5 after birth.
3. The mouse model of claim 2 , wherein the mice are fed the alcohol-containing diet starting on day 56±14 days after birth.
4. The mouse model of claim 3 wherein the mouse is fed the alcohol-containing diet for at least four months.
5. The mouse model of claim 1 , wherein the alcohol-containing diet consists of an alcohol-liquid diet.
6. The mouse model of claim 1 , wherein the alcohol-containing diet contains about 30% to about 40% of total calories from ethanol.
7. A method of screening drugs for efficacy in preventing or treating alcoholic steatohepatitis (ASH)-associated hepatocellular carcinoma (HCC) comprising administering the drugs to one or more mice of claim 1 and monitoring growth of HCC in the one or more mice.
8. A method of generating an alcohol-induced liver cancer model mouse comprising (a) administering streptozotocin to a 2-5 day old mouse in an amount sufficient to induce a diabetic phenotype in the mouse and (b) feeding the mouse an alcohol-containing diet.
9. The method of claim 8 , wherein the streptozotocin is administered to the mouse on day 2 after birth.
10. The method of claim 9 , wherein the alcohol-containing diet is started on day 56±14 days after birth.
11. The method of claim 10 , wherein the mouse is fed the alcohol-containing diet for at least four months.
12. The mouse model of claim 8 , wherein the alcohol-containing diet consists of an alcohol-liquid diet.
13. The method of claim 8 , wherein the alcohol-containing diet contains about 30% to about 40% of the total calories from the ethanol.
14. A method of identifying biomarkers for hepato-carcinogenesis in alcoholic liver disease (ALD) comprising generating an alcohol-induced liver cancer model mouse as described in claim 11 , analyzing gene expression in a tumor in the model mouse, and comparing expression of the same gene in an adjacent tissue in the same mouse or a control mouse, wherein an increase or decrease in expression of the gene relative to the adjacent tissue or control mouse indicates the gene is a biomarker for hepato-carcinogenesis in ALD.